@adrianabello

pediatrician, pediatric hematologyst, mother [email protected]

Joined July 2009
  • Tweets21.6K
  • Following3.3K
  • Followers1.9K
355Media
I am deeply honored and humbled to step into the role of President of @SocietyofHemOnc, succeeding the exceptional Dr. @garciamanero, who led with excellence the Society in 2023-2024. I have big shoes to fill! My sincere thanks to #SOHO, the Board, and the Steering Committee for your trust and confidence. @DrHKantarjian @JanetCesak
15
9
3
108
7,991
Look at those heavy hitters 🤩 #LATM #SOHO2024
2
2
1
40
2,463
MDS-710 AYA With GATA2 Deficiency Syndrome With Evolving Myeloid Neopl... sciencedirect.com/science/ar…
1
126
AML-106 From Clonal Evolution to Posttransplant Relapse—Case Report of... sciencedirect.com/science/ar…
101
MM-107 Teclistamab Success in CAR-T Refractory Multiple Myeloma: A Cas... sciencedirect.com/science/ar…
1
142
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial - The Lancet Haematology thelancet.com/journals/lanha…
124
Another day in the life of a #hematopathologist….. To say I love😍 this job is an understatement. Never a dull moment @ #hemepathMDA…. Sharing some of the more photogenic cases we saw on service in this #hemepath 🧵... in the order they appeared on my 🔬 1/ Let's learn..
4
56
258
47,817
Listen to "Beyond Remission: Navigating the Late Effects of Pediatric CAR T-Cell Therapy" by ASTCT Talks podcasters.spotify.com/pod/s…

Beyond Remission: Navigating the Late Effects of Pediatric CAR T-Cell Therapy by ASTCT Talks

In this episode "ASTCT Talks,” hosts Rebecca Epperly, MD, and Aimee Talleur, MD, from St. Jude Children's Research Hospital, dive into the pioneering realm of CAR T-cell therapy and its late effects...

creators.spotify.com
119
POSTER: TCL-196 Hepatosplenic T-Cell Lymphoma in Adolescents and Young Adults: A Case Report - Clinical Lymphoma, Myeloma and Leukemia clinical-lymphoma-myeloma-le…
140
Ok embarrassed to admit this but I never completed my HPV vaccination series until yesterday. (Also excuse my scratchy voice)!
51
44
7
505
64,626
Mar Galcerán makes history as Spain’s first parliamentarian with Down’s syndrome theguardian.com/world/2024/j…

Mar Galcerán makes history as Spain’s first parliamentarian with Down’s syndrome

After being elected to Valencia’s regional assembly, Galcerán says she wants to be seen as a person, not for her disability

theguardian.com
2
180
Updated treatment approach to newly diagnosed myeloma based on new #ASH23 data. Explanation for changes in thread. #MedTwitter 1/
13
156
13
397
108,371
Though very excited about #genetherapy for #SickleCellDisease, Debaun presented this sobering slide at #ASH23: we don’t use already approved therapies (especially hydroxyurea) enough!
2
10
769
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A | Science science.org/doi/10.1126/scie…

Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A

Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identif...

science.org
118
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease fda.gov/news-events/press-an…

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.

fda.gov
73
Adriana Bello retweeted
Shematologist, MD@acweyand1 Nov 2023
Almost 40% of young women in the US are iron deficient! tinyurl.com/JAMAIron Thanks to @theSkimm for continuing to get the word out! theskimm.com/wellness/iron-d…

Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020

This study examines prevalence of iron deficiency among females aged 12 to 21 years to inform future screening strategies for iron deficiency and iron-deficiency anemia.

jamanetwork.com
10
33
3
149
30,276
“Si tenemos algo que funciona bien, mejor lo damos de primera línea, porque si no, igual no llega al paciente de la segunda línea o a la tercera línea” ⁦@DrMiguelPerales⁩ elpais.com/salud-y-bienestar…

Miguel Ángel Perales, oncólogo: “Lo que estamos haciendo hoy con la terapia celular CAR-T contra el...

El científico del Memorial Sloan Kettering de Nueva York asegura que esta técnica ha significado “un cambio total” del pronóstico de muchos enfermos

elpais.com
1
12
1
40
3,078
Screening With Reticulocyte Hemoglobin Increased Iron... : Pediatric Quality & Safety journals.lww.com/pqs/fulltex…

Screening With Reticulocyte Hemoglobin Increased... : Pediatric Quality & Safety

Introduction:To increase the rate of iron sufficiency among neonatal intensive care unit (NICU) patients from 16% to >35% within 12 months of...

ovid.com
46
Iron Nutrition, Erythrocytes, and Erythropoietin in the NICU: Erythropoietic and Neuroprotective Effects publications.aap.org/neorevi…

Iron Nutrition, Erythrocytes, and Erythropoietin in the NICU: Erythropoietic and Neuroprotective...

Prematurity, maternal diabetes, maternal smoking, being medically underserved, and small size for gestational age are common characteristics of neonates in the NICU and can predispose them to develop...

publications.aap.org
1
48
High-risk babies: It’s not enough to survive — we want them to thrive nature.com/articles/d42473-0…
69
Load more